AvingerAVGR
About: Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Employees: 76
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
1.78% more ownership
Funds ownership: 4.33% [Q2] → 6.11% (+1.78%) [Q3]
0% more funds holding
Funds holding: 12 [Q2] → 12 (+0) [Q3]
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
18% less capital invested
Capital invested by funds: $164K [Q2] → $134K (-$29.9K) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for AVGR.
Financial journalist opinion
Based on 5 articles about AVGR published over the past 30 days
